Late Breaking Abstract - Impact of the SARS-CoV-2 pandemic on incidence and phenotype of tuberculosis in a UK hotspot
J. Kim (Leicester, United Kingdom), R. Patel (Leicester, United Kingdom), D. Bell (Leicester, United Kingdom), M. Pareek (Leicester, United Kingdom), H. Thuraisingam (Leicester, United Kingdom), J. Lee (Leicester, United Kingdom), A. Gilmour-Caunt (Leicester, United Kingdom), L. Yorke (Leicester, United Kingdom), G. Woltmann (Leicester, United Kingdom), R. Verma (Leicester, United Kingdom), P. Haldar (Leicester, United Kingdom)
Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kim (Leicester, United Kingdom), R. Patel (Leicester, United Kingdom), D. Bell (Leicester, United Kingdom), M. Pareek (Leicester, United Kingdom), H. Thuraisingam (Leicester, United Kingdom), J. Lee (Leicester, United Kingdom), A. Gilmour-Caunt (Leicester, United Kingdom), L. Yorke (Leicester, United Kingdom), G. Woltmann (Leicester, United Kingdom), R. Verma (Leicester, United Kingdom), P. Haldar (Leicester, United Kingdom). Late Breaking Abstract - Impact of the SARS-CoV-2 pandemic on incidence and phenotype of tuberculosis in a UK hotspot. 1608
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: